account_balance
Investment manager · 13F filer · SEC CIK 1964437
Saturn V Capital Management LP
Reported value$697Mas of Jun 30, 2026
Positions23 3 new, 1 sold out
Top 10 weight75.6%AMLX alone is 12%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
The top 10 stocks are 75.6% of this fund. 13 other stocks make up the rest.
AMLX Amylyx Pharmaceuticals Inc 11.9% Added +6%ALMS Alumis Inc 11.8% Trimmed −9%ABVX Abivax SA 9.9% Trimmed −4%PCVX Vaxcyte Inc 7.1% Added +3%IMMX Immix Biopharma Inc 6.9% Added +26%PHVS Pharvaris N V 6.5% Added +9%JAZZ Jazz Pharmaceuticals PLC 5.6% HeldCELC Celcuity Inc 5.6% Added +31%IRON Disc Medicine Inc 5.5% Added +17%CADL Candel Therapeutics Inc 4.9% Added +14%
13 other stocks24.4%
Bar length compares each stock with the biggest holding. Tags compare share counts with the Mar 31, 2026 filing. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed